parkinsons-disease

BackgroundPost-translational modifications, particularly SUMOylation, plays a crucial role in α-synuclein (α-syn) aggregation, a key pathological feature of Parkinson’s disease (PD). Curcumin, a natural polyphenol, has shown neuroprotective potential, but its effects on SUMOylation-related signaling in PD remain unclear.ObjectiveThis study aimed to investigate whether curcumin modulates α-syn SUM…

Parkinson’s disease is a long-term brain disorder that mainly affects movement. As the disease progresses, people may develop slower movements, stiffness, shaking, balance problems, and difficulty walking. These symptoms often change throughout the day depending on medication and the stage of the disease. Because of this, doctors need accurate information about how a person moves […] The post New…

Parkinson’s disease is a complex neurodegenerative disorder that, over time, impairs the ability to move and affects a wide range of other non-movement-related functions. For scientists, one of the biggest […] Van Andel Institute - Van Andel Institute transforms human health through groundbreaking biomedical research and cutting-edge science education.

BackgroundFreezing of gait (FOG) is one of the most debilitating motor symptoms in Parkinson’s disease (PD), affecting a substantial proportion of people with PD. Numerous hypothetical mechanisms exist, attempting to explain FOG. Current evidence originated from stationary measures in lying positions, limiting the understanding of neurophysiological changes elicited by FOG episodes during regular…

Parkinson’s disease is a long-term brain disorder that slowly gets worse over time. It mainly affects movement because it damages brain cells that produce dopamine, a chemical that helps control smooth and coordinated muscle movements. People with Parkinson’s disease may develop shaking, stiff muscles, slow movement, poor balance, and difficulty walking. As the disease progresses, […] The post Th…

Non-motor symptoms (NMS) in Parkinson’s disease (PD) are highly prevalent and significantly impact quality of life. However, they are under-recognized and undertreated. Current classification systems of NMS inadequately reflect the phenomenological complexity and interrelationship of these symptoms. In this narrative review, we synthesized recent evidence about NMS in PD to critically appraise th…

BackgroundMicroRNA-7-5p (miR-7-5p) may play a neuroprotective role in people with Parkinson’s disease (PwP), as it has been found to regulate α-synuclein (α-syn) and the NLRP3 inflammasome in animal models of Parkinson’s disease (PD).ObjectiveThe study aimed to investigate the use of miR-7-5p as a potential biomarker for disease progression in PwP by correlating it with time, clinical measures, a…

Copied to clipboard Dopamine is more than the “rush molecule”. This chemical messenger, produced by neurons in the midbrain, acts as a traffic controller that regulates the flow of electrical signals between neurons, assisting with brain functions like cognition, attention, movement, and behavior. But, in instances of Parkinson’s disease (PD), a progressive brain disorder, dopamine-producing […] …